Stephen J. DiPalma - May 17, 2021 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
Interim CFO
Signature
/s/ Damon Banks, as attorney-in-fact for Stephen DiPalma
Stock symbol
INZY
Transactions as of
May 17, 2021
Transactions value $
$0
Form type
4
Date filed
5/18/2021, 04:18 PM
Next filing
Jul 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INZY Stock option (Right to Buy) Award $0 +15K $0.00 15K May 17, 2021 Common Stock 15K $15.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on May 17, 2021 and will vest as to 50% of the shares underlying the option on the date that is 180 days following the grant date and as to the remaining 50% of the shares underlying the option on the first anniversary of the grant date, provided Mr. DiPalma is providing services to the Company on such dates.